from Guyton and Hall Textbook of Medical Physiology (4th South Asia Edition) write a proper 7 mark short note on Lung Compliance- describe, factors affecting ; hyaline membrane disease

Reading File

Finding Sources

Reading File

Lung Compliance and Hyaline Membrane Disease

(Guyton and Hall, Textbook of Medical Physiology, 4th South Asia Edition)

1. Definition

Lung compliance is defined as the extent to which the lungs expand for each unit increase in transpulmonary pressure (alveolar pressure minus pleural pressure), provided sufficient time is allowed to reach equilibrium.

Total compliance of both lungs together in a normal adult averages ~200 mL of air per cm H2O of transpulmonary pressure.
That is, for every 1 cm H2O rise in transpulmonary pressure, lung volume expands by 200 mL after 10-20 seconds.

Compliance Diagram: Plotting lung volume changes against transpulmonary pressure changes gives separate curves for inspiration and expiration (inspiratory and expiratory compliance curves), together called the compliance diagram of the lungs. This diagram is determined by the elastic forces of the lungs, which arise from two sources:

Elastic forces of the lung tissue itself (elastin and collagen fibers of the parenchyma).
Elastic forces caused by surface tension of the fluid lining the alveolar walls.

Book Title: Guyton and Hall Textbook of Medical Physiology, p. 494

2. Factors Affecting Lung Compliance

A. Elastic forces of lung tissue Determined mainly by elastin and collagen fibers interwoven through the lung parenchyma. In the deflated state these fibers are contracted and kinked; on lung expansion they stretch and unkink, generating increasing elastic recoil.

B. Surface tension forces (alveolar fluid-air interface) These are more complex and, in fact, contribute the major share of the elastic resistance in the normal lung.

Demonstrated by comparing air-filled versus saline-filled lungs: saline abolishes the air-fluid interface (and hence surface tension), leaving only tissue elastic forces - such lungs are far more compliant and easier to inflate.
Surfactant, secreted by type II alveolar epithelial cells, reduces alveolar surface tension 2- to 10-fold. This is the principal physiological factor that increases compliance and prevents alveolar collapse; without adequate surfactant, compliance falls sharply.

C. Other factors

Pulmonary fibrosis / edema / congestion - decreases compliance (stiffer lungs, more pressure needed for a given volume change).
Emphysema - loss of elastic tissue increases compliance (lungs become more distensible but lose recoil).
Age - compliance tends to increase somewhat with advancing age due to loss of elastic tissue.
Chest wall/thoracic factors - compliance of the thorax and lungs together is roughly half that of the lungs alone (~110 mL/cm H2O for the combined system), since the chest wall itself has elastic resistance.
Pulmonary blood volume/congestion and absence of surfactant both reduce compliance and predispose to atelectasis.

3. Hyaline Membrane Disease (Respiratory Distress Syndrome)

Mechanism: Surfactant-secreting type II alveolar epithelial cells do not begin adequate secretion until the last 1-3 months of gestation. Premature infants (and occasionally full-term infants, especially of diabetic mothers) may therefore be born without sufficient surfactant.

Consequences:

Alveolar surface tension rises several-fold above normal, producing a strong tendency for alveolar collapse (atelectasis) and reduced lung compliance.
At death, the alveoli of affected infants contain large quantities of proteinaceous fluid, almost as though plasma had leaked from the capillaries into the alveoli, together with desquamated alveolar epithelial cells.
Microscopically, this fluid coats the alveoli in a layer resembling a "hyaline membrane" - hence the name hyaline membrane disease, also called respiratory distress syndrome (RDS) of the newborn.
The combination of alveolar collapse and pulmonary edema causes severe respiratory distress; without treatment many infants die of suffocation as large portions of lung become atelectatic. The more premature the infant, the more severe the disease.

Treatment: Exogenous surfactant administration, assisted ventilation, and antenatal corticosteroids have greatly improved survival, although the condition remains an important cause of neonatal morbidity and mortality.

Book Title: Guyton and Hall Textbook of Medical Physiology, p. 546, 1050-1051

Note on recent evidence: Current neonatology guidelines continue to support antenatal corticosteroids and early surfactant therapy (with less invasive surfactant administration techniques) as standard of care for RDS in preterm infants; this aligns with and extends the textbook's description and does not contradict it. For exam purposes, the physiological description above from Guyton and Hall is sufficient and authoritative.

This is a shared conversation. Sign in to Orris to start your own chat.